MCI, vascular cognitive decline and early Alzheimer’s disease
Early cognitive decline deserves a broader analysis than simply asking whether someone has Alzheimer’s disease. Vascular damage, sleep, medication, blood pressure, metabolic factors and neurodegeneration may all contribute.
Evidence status: Conventional diagnostics + China-specific treatment optionsWhat is the medical problem?
Mild Cognitive Impairment and early cognitive decline can have different causes. Not everyone with memory complaints has Alzheimer’s disease. Particularly at an early stage, treatable factors such as vascular risk, sleep apnoea, medication, depression, hearing loss and metabolic disorders are important.
What could a treatment pathway look like?
The first step is to distinguish between MCI, Alzheimer’s disease, vascular cognitive impairment and other causes. Reversible or modifiable factors are then addressed systematically. Cognitive scores are measured before and after treatment using the same instruments.
What do we know about effectiveness?
There is a strong rationale, and depending on the intervention good evidence, for vascular risk reduction, exercise, sleep treatment and treatment of underlying conditions. GV-971 is registered in China for mild to moderate Alzheimer’s disease and has been studied in a large phase III trial, but it is not a standard European Alzheimer’s treatment. Positive RCTs exist for specialised acupuncture, but it remains adjunctive care.
Important selection considerations
No ‘cure for Alzheimer’s’ is promised. New or rapidly progressive cognitive symptoms require standard neurological assessment first. Medication and indications for biomarker testing must be determined by a specialist.
Medical selection before travel
The options described are not a guarantee of treatment. Availability and suitability depend on diagnosis, indication, evidence level, individual risks and assessment by the treating medical team. Experimental care is identified as such.
Would you like to know whether a pathway could be medically appropriate?
A treatment journey always begins with an assessment of the diagnosis, medical history, previous treatments, medication, risks and the specific treatment objective.